logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yasuhiro Gotô

Fujita Health University School of Medicine
H指数:31
被引数:3,791

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of Intratumoral PD-L1 Expression on Treatment Efficacy of ALK Tyrosine Kinase Inhibitors for Advanced or Recurrent ALK-Positive Non-small Cell Lung Cancer

肿瘤内PD-L1表达对晚期或复发性ALK阳性非小细胞肺癌ALK酪氨酸激酶抑制剂治疗疗效的影响

Medical Oncology
IF3.5
2026-10-260
PRE
Ryo Sawada; Tadaaki Yamada; Yasuhiro Goto; Yoshiki Negi; Akira Nakao; Akihiro Yoshimura; Naoki Furuya; Tomohiro Oba; Makoto Hibino; Haruka Nakatani; Hirokazu Taniguchi; Aya Ohtsubo; Satoshi Watanabe; Takahiro Yamada; Yusuke Chihara; Takashi Kijima; Koichi Takayama
Regimen selection for combined immunotherapy in non-small cell lung cancer with PD-L1 < 1%: a multicenter, retrospective study from Japan (SPIRAL-LT1)

PD-L1<1%的非小细胞肺癌联合免疫治疗方案选择：一项来自日本的多中心回顾性研究（SPIRAL-LT1）

Scientific Reports
IF3.9
2026-10-160
OAAI
Daiki Murata; Koichi Azuma; Kenta Murotani; Kazuhiro Ito; Takashi Nomizo; Kazuhiko Yamada; Tatsuya Imabayashi; Kentaro Iwanaga; Kenji Chibana; Takayo Ota; Yuuya Nishii; Akira Nakao; Asuka Okada; Kosuke Hamai; Keiko Tanimura; Kohei Yoshimine; Yosuke Tamura; Ryuichiro Takaki; Yasuhiro Goto; Makoto Hibino; Tomohiro Oba; Toshiyuki Sumi; Hiroyasu Kaneda; Naoya Nishioka; Tadaaki Yamada; Koichi Takayama
Predictive value of TTF-1 expression for stratifying outcomes between dual ICI and chemoimmunotherapy in patients with PD-L1-negative NSCLC

TTF-1表达对PD-L1阴性NSCLC患者接受双重ICI与化疗联合免疫疗法预后分层的预测价值

International Journal of Clinical Oncology
IF2.8
2026-08-040
PRE
Naoya Nishioka; Daiki Murata; Koichi Azuma; Kazuhiro Ito; Takashi Nomizo; Kazuhiko Yamada; Tatsuya Imabayashi; Kentaro Iwanaga; Kenji Chibana; Takayo Ota; Yuuya Nishii; Akira Nakao; Asuka Okada; Kosuke Hamai; Takenori Sakai; Taishi Harada; Keiko Tanimura; Kohei Yoshimine; Yosuke Tamura; Ryuichiro Takaki; Yasuhiro Goto; Makoto Hibino; Tomohiro Oba; Toshiyuki Sumi; Hiroyasu Kaneda; Tadaaki Yamada; Koichi Takayama
Identification of Hidden Cachexia Subgroup in PD-L1-High NSCLC: Comparative Analysis of the AWGC vs. Fearon Criteria

识别PD-L1高表达非小细胞肺癌中隐藏恶病质亚组：AWGC与Fearon标准的比较分析

journal of cachexia, sarcopenia and muscle
IF0
2026-04-120
OAAI
Naoya Nishioka; Hayato Kawachi; Tadaaki Yamada; Motohiro Tamiya; Yoshiki Negi; Yasuhiro Goto; Akira Nakao; Shinsuke Shiotsu; Keiko Tanimura; Takayuki Takeda; Asuka Okada; Taishi Harada; Koji Date; Yusuke Chihara; Isao Hasegawa; Nobuyo Tamiya; Takeo Ogawa; Masahiro Iwasaku; Shinsaku Tokuda; Takashi Kijima; Koichi Takayama
AXL–SHC1 signaling axis mediates adaptive resistance to HER2-targeted tyrosine kinase inhibitors in HER2-aberrant lung and gastric cancers

AXL–SHC1信号轴介导了HER2-aberrant肺癌和胃癌对HER2靶向酪氨酸激酶抑制剂的适应性耐药。

npj Precision Oncology
IF8
2026-04-020
OAAI
Masaki Ishida; Tadaaki Yamada; Yuki Katayama; Hayato Kawachi; Ryo Sawada; Ryota Nakamura; Soichi Hirai; Yohei Matsui; Kenji Morimoto; Keisuke Onoi; Aosa Nakamura-Sasada; Mano Horinaka; Toshiyuki Sakai; Tomoki Sakakida; Toshifumi Doi; Kazuo Yasumoto; Yasuhiro Goto; Naoki Furuya; Hirokazu Taniguchi; Hirokazu Ogino; Nakano Takayuki; Yusuke Chihara; Koji Fukuda; Hiroaki Taniguchi; Hisanori Uehara; Seiji Yano; Shinsaku Tokuda; Koichi Takayama
Selecting optimal immunotherapy based on inflammation in stage IV PD-L1 ≥50% gene mutation-negative non-small cell lung cancer: pembrolizumab monotherapy versus combination chemoimmunotherapy

基于炎症选择最优免疫疗法：用于PD-L1 ≥50%基因突变阴性IV期非小细胞肺癌：帕博利珠单抗单药治疗与联合化疗免疫疗法

TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2025-11-300
PRE
Kunimatsu, Yusuke; Nishioka, Naoya; Yamada, Tadaaki; Kawachi, Hayato; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Ishida, Masaki; Kijima, Takashi; Takayama, Koichi
High diagnostic yield and treatment impact of bronchoscopy in elderly lung cancer patients (> 80 years): A single-center retrospective study

支气管镜检查在80岁以上老年肺癌患者中的诊断收益和治疗影响：一项单中心回顾性研究

RESPIRATORY INVESTIGATION
IF2
2025-11-010
OAAI
Maeda, Shingo; Ina, Takuma; Ota, Atsuhiko; Matsunaga, Masaaki; Horiguchi, Tomoya; Ikeda, Aki; Moriya, Ryoma; Sato, Takaya; Sawada, Chiaki; Oya, Yuko; Okachi, Shotaro; Goto, Yasuhiro; Isogai, Sumito; Hashimoto, Naozumi; Kondo, Masashi; Imaizumi, Kazuyoshi
Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression
ANTICANCER RESEARCH
IF1.7
2025-11-011
PRE
Sasada, Aosa; Kawachi, Hayato; Yamada, Tadaaki; Hata, Tae; Goto, Yasuhiro; Amano, Akihiko; Negi, Yoshiki; Watanabe, Satoshi; Furuya, Naoki; Oba, Tomohiro; Ikoma, Tatsuki; Nakao, Akira; Tanimura, Keiko; Taniguchi, Hirokazu; Yoshimura, Akihiro; Fukui, Tomoya; Murata, Daiki; Kaira, Kyoichi; Shiotsu, Shinsuke; Okada, Asuka; Chihara, Yusuke; Kijima, Takashi; Takayama, Koichi
Immune checkpoint inhibitor-induced interstitial lung disease with and without CTLA-4 regimen in non-small cell lung cancer patients and PD-L1 < 1 %: A multicenter, retrospective study

免疫检查点抑制剂诱导的间质性肺病（合并与不合并CTLA-4方案）在PD-L1 < 1 %的非小细胞肺癌患者中的研究：一项多中心、回顾性研究

Lung Cancer
IF4.4
2025-09-260
PRE
Daiki Murata; Koichi Azuma; Kenta Murotani; Kazuhiro Ito; Takashi Nomizo; Kazuhiko Yamada; Tatsuya Imabayashi; Kentaro Iwanaga; Kenji Chibana; Takayo Ota; Yuuya Nishii; Akira Nakao; Asuka Okada; Kosuke Hamai; Keiko Tanimura; Kohei Yoshimine; Yosuke Tamura; Ryuichiro Takaki; Yasuhiro Goto; Makoto Hibino; Tomohiro Oba; Toshiyuki Sumi; Hiroyasu Kaneda; Naoya Nishioka; Tadaaki Yamada; Koichi Takayama
Pemetrexed plus platinum as second-line treatment for patients with pleural mesothelioma treated with nivolumab plus ipilimumab

培美曲塞联合铂类药物作为接受纳武利尤单抗联合伊匹木单抗治疗的患者中，恶性胸膜间皮瘤的二线治疗方案。

Lung Cancer
IF4.4
2025-08-120
PRE
Sawana Ono; Hirokazu Taniguchi; Koji Kuroda; Teppei Hashimoto; Asuka Okada; Yasuhiro Goto; Hidenori Kitai; Yoichi Nakamura; Shinsuke Ogusu; Tetsunari Hase; Takayo Ota; Noriyuki Ebi; Makoto Furugen; Taishi Harada; Yoshiaki Kinoshita; Takaki Mizoguchi; Katsumi Nakatomi; Yoshifumi Soejima; Takahiro Yamada; Shinnosuke Takemoto; Hiroshi Mukae
Analysis of Poor Prognostic Factors and Treatment Strategies in Platinum-Based Systemic Therapy After EGFR-TKI Failure in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations

携带EGFR突变的患者在EGFR-TKI失败后接受铂类为基础的系统治疗中不良预后因素及治疗策略的分析

Clinical Lung Cancer
IF3.3
2025-07-220
PRE
Tae Hata; Tadaaki Yamada; Naoki Furuya; Hisashi Tanaka; Akihiro Yoshimura; Tomohiro Oba; Makoto Hibino; Takahito Fukuda; Yasuhiro Goto; Akira Nakao; Shinsuke Ogusu; Yuta Okazaki; Taishi Harada; Takayo Ota; Ken Masubuchi; Koji Mikami; Shoki Matsumoto; Ryoichi Honda; Koji Date; Yusuke Chihara
Real-world treatment outcomes before and after chemoimmunotherapy approval in EGFR-mutant NSCLC after EGFR-TKI failure: a Japanese cohort study

EGFR突变非小细胞肺癌在EGFR-TKI治疗失败后，化疗免疫疗法批准前后真实世界治疗结局：一项日本队列研究

international journal of oncology
IF2.8
2025-07-220
PRE
Kenji Morimoto; Tadaaki Yamada; Naoki Furuya; Hisashi Tanaka; Akihiro Yoshimura; Tomohiro Oba; Makoto Hibino; Takahito Fukuda; Yasuhiro Goto; Akira Nakao; Shinsuke Ogusu; Yuta Okazaki; Taishi Harada; Takayo Ota; Ken Masubuchi; Koji Mikami; Tae Hata; Shoki Matsumoto; Ryoichi Honda; Koji Date; Yusuke Chihara; Koichi Takayama
Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy
ONCOIMMUNOLOGY
IF6.3
2024-12-160
OAAI
Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Kijima, Takashi; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Katayama, Yuki; Nishioka, Naoya; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Shimose, Takayuki; Takayama, Koichi

研究方向

暂未获取到该数据
T
Tadaaki Yamada
H 指数:41论文数:563被引数:6,283
Y
Yusuke Chihara
H 指数:23论文数:157被引数:3,149
K
Koichi Takayama
H 指数:75论文数:954被引数:1.9万
A
Akira Nakao
H 指数:21论文数:139被引数:1,347
T
Takayuki Takeda
H 指数:22论文数:196被引数:2,735
A
Asuka Okada
H 指数:11论文数:105被引数:402
T
Taishi Harada
H 指数:32论文数:221被引数:3,854
K
Kazuyoshi Imaizumi
H 指数:36论文数:345被引数:4,710
S
Shinsuke Shiotsu
H 指数:17论文数:121被引数:1,388
T
Takashi Kijima
H 指数:34论文数:393被引数:5,365